Exact Sciences
EXAS
#1175
Rank
C$28.07 B
Marketcap
C$147.05
Share price
0.00%
Change (1 day)
123.36%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): C-$7.63

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.46. In 2024 the company made an earnings per share (EPS) of C-$7.81.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$7.63-2.26%
2024C-$7.81
2022C-$4.962.31%
2021C-$4.85-38.54%
2020C-$7.89692.96%
2019C-$1.00-50.69%
2018C-$2.0244%
2017C-$1.40-39.39%
2016C-$2.31-2.94%
2015C-$2.3837.1%
2014C-$1.7479.71%
2013C-$0.97-21.59%
2012C-$1.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$3.59-148.11%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
C$1.56-120.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.48-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$6.03-19.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$71.35 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA